|
Wednesday, April 17, 2002
Opening Remarks/Day One Summary
Stanley Lemon
Vice Chair, Forum on Emerging Infections
Listen
Session III: Creating Opportunities from Globalization : A Framework for Progress
Moderator: Michael Zeilinger, U.S. Agency for International Development
Listen
Globalization and Health: A Framework for Analysis and Action
Douglas Klaucke, World Health Organization
Listen
New Directions in Capacity Building
Pierce Gardner, Fogerty International Center
Listen
Partnering for Success: The Role of Private-Public Sector Collaboration
Roy Widdus, Initiative for Public-Private Partnerships for Health, Geneva
Listen
The Current Situation and Perspectives of International Collaboration in the Field of Biomedical Sciences: The Example of the State Research Center of Virology and Biotechnology, VECTOR
Sergei Netesov, VECTOR Laboratories, Koltsovo, Russia
Listen
Protecting the Nation's Health in an Era of Globalization, CDC's Global Infectious Disease Strategy
Eric Mintz, Centers for Disease Control and Prevention
Listen
The Global Fund: A Brave New World
William Steiger, Office of the Secretary, Department of Health and Human Services
Listen
Invited Discussion: Considerations for Shaping the Agenda
Moderator: Carlos Lopez, Eli Lilly and Company
Olusoj Adeyi, The World Bank
Listen
Mark Miller, Fogarty International Center
Listen
Ralph Timperi, Chair, APHL Global Health Committee
Listen
Session IV: The Global Application of Tools, Technology, and Knowledge to Counter the Consequences of Infectious Diseases:
A Discussion of Priorities and Options
With the backdrop of the two days' presentations and discussion, Forum members, panel discussants, and the audience will comment on the issues and next steps that they would identify as priority areas for consideration within industry, academia, government agencies, public health organizations, and other non-governmental organizations. The discussion of priorities will summarize the issues surrounding emerging opportunities for more effective collaboration as well as the options and considerations for research, development, and capacity building. The complexities of interaction between private industry, research and public health agencies, regulatory agencies, policymakers, academic researchers, and the public will be explored with an eye toward innovative responses to the challenges and opportunities presented by an increasingly "globalized" world.
Moderator: Adel Mahmoud, Merck Vaccines
Listen
Invited Panel Discussants:
Reinhard Kurth, President, The Robert Koch Institute
Listen
Eduardo Gotuzzo, University Perudad Cayetano Heredia, Peru
Listen
Jim LeDuc, Centers for Disease Control and Prevention
Listen
Roundtable Discussion
Closing Remarks / Adjournment
Adel Mahmoud
Chair, Forum on Emerging Infections
|